Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China flag China · Delayed Price · Currency is CNY
8.98
-0.15 (-1.64%)
Nov 18, 2026, 3:00 PM CST

Shanghai No.1 Pharmacy Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
309.6322.59436.42400.03504.93262.28
Short-Term Investments
31.3698.0485.6266.2940-
Trading Asset Securities
24.281.0315.3830.15220.29-
Cash & Short-Term Investments
365.24421.67537.41496.47765.22262.28
Cash Growth
-31.53%-21.54%8.25%-35.12%191.75%-48.51%
Accounts Receivable
236.67189.88190.15247.57238133.56
Other Receivables
64.2446.9730.423.3127.131.32
Receivables
300.91236.85220.55270.88265.1164.87
Inventory
360.67354.94336.32332.23334.75214.5
Prepaid Expenses
-7.159.393.520.780.44
Other Current Assets
19.7636.4223.3314.1331.2920.59
Total Current Assets
1,0471,0571,1271,1171,397662.69
Property, Plant & Equipment
207.05253.56260.88215.36181.09167.98
Long-Term Investments
290.95358.86342.74322.45252.47184.14
Other Intangible Assets
34.8136.4638.9341.6743.8346.33
Long-Term Deferred Tax Assets
28.2626.7624.3526.3935.9912.07
Long-Term Deferred Charges
21.7424.5720.5816.2814.439.28
Other Long-Term Assets
276.6264.09165.58123.78114.15251.97
Total Assets
1,9062,0211,9801,8632,0391,334

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
470.45454.1384.14398.59363.69314.8
Accrued Expenses
1.9824.3526.5127.0932.5715.02
Short-Term Debt
-49.995.58101.05320.28-
Current Portion of Leases
55.7163.4863.9858.3449.0538.94
Current Income Taxes Payable
4.931.260.910.2737.335.93
Current Unearned Revenue
8.723.555.365.7125.532.71
Other Current Liabilities
66.5869.8571.6875.7497.9166.64
Total Current Liabilities
608.36666.49648.15676.79926.37444.04
Long-Term Leases
85.34107.82115.56107.2488.3363.08
Long-Term Unearned Revenue
11.1611.511.9712.4411.311.68
Pension & Post-Retirement Benefits
2.372.392.52.42--
Long-Term Deferred Tax Liabilities
51.4762.2557.4855.8354.3437.34
Other Long-Term Liabilities
----0.070.4
Total Liabilities
758.69850.46835.66854.721,080556.54

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
223.09223.09223.09223.09223.09223.09
Additional Paid-In Capital
65.5365.5365.5365.1965.1965.19
Retained Earnings
698.15688.65679.98544.95499.18371.24
Comprehensive Income & Other
150.42184.02167.01168.22164.22111.4
Total Common Equity
1,1371,1611,1361,001951.67770.92
Minority Interest
10.099.588.797.017.017.01
Shareholders' Equity
1,1471,1711,1441,008958.68777.92
Total Liabilities & Equity
1,9062,0211,9801,8632,0391,334

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
141.05221.21275.12266.63457.67102.03
Net Cash (Debt)
224.19200.46262.29229.83307.55160.26
Net Cash Growth
-24.71%-23.57%14.12%-25.27%91.91%-51.34%
Net Cash Per Share
1.010.901.171.031.370.71
Filing Date Shares Outstanding
223.09223.09223.09223.09223.09223.09
Total Common Shares Outstanding
223.09223.09223.09223.09223.09223.09
Working Capital
438.21390.53478.85440.44470.77218.65
Book Value Per Share
5.105.215.094.494.273.46
Tangible Book Value
1,1021,1251,097959.77907.85724.58
Tangible Book Value Per Share
4.945.044.924.304.073.25
Buildings
-101.59105.1989.3494.7694.76
Machinery
-27.3626.9626.522626.32
Construction In Progress
-7.785.741.741.432.24